Guy Baudens

Valenciennes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network.

Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network.

Journal: Scientific reports
Published: July 08, 2022

Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study.

Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study.

Journal: Frontiers in medicine
Published: July 08, 2022

Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.

Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.

Journal: Rheumatology international
Published: November 09, 2021

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study.

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study.

Journal: Rheumatology and therapy
Published: August 27, 2020

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.

Journal: Rheumatology (Oxford, England)
Published: June 26, 2020

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network.

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network.

Journal: Journal of clinical medicine
Published: April 09, 2020

Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study.

Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study.

Journal: Rheumatology and therapy
Published: October 31, 2018

Autoimmune thyroid disorders during anti-TNF alpha therapy: coincidence, paradoxical event or marker of immunogenicity?

Autoimmune thyroid disorders during anti-TNF alpha therapy: coincidence, paradoxical event or marker of immunogenicity?

Journal: Joint bone spine
Published: August 26, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026